These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 19555363)

  • 1. Myelodysplastic syndromes: the role of flow cytometry in diagnosis and prognosis.
    Stetler-Stevenson M; Yuan CM
    Int J Lab Hematol; 2009 Oct; 31(5):479-83. PubMed ID: 19555363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Research advances in value of flow cytometric immunophenotyping in diagnosis and prognostic evaluation of myelodysplastic syndrome].
    Lu D; Liu YR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):785-90. PubMed ID: 23815941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multiparametric flow cytometry immunophenotypic scoring system for the diagnosis and prognosis of myelodysplastic syndromes.
    Huang J; Lai P; Zhou M; Weng J; Lu Z; Du X
    Clin Lab; 2012; 58(11-12):1241-51. PubMed ID: 23289195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of bone marrow cells immunophenotypic study by flow cytometry in diagnosing myelodysplastic syndrome].
    Czyz A; Dworacki G; Komarnicki M
    Postepy Hig Med Dosw (Online); 2008 Jul; 62():354-63. PubMed ID: 18688206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow cells from myelodysplastic syndromes show altered immunophenotypic profiles that may contribute to the diagnosis and prognostic stratification of the disease: a pilot study on a series of 56 patients.
    Matarraz S; López A; Barrena S; Fernandez C; Jensen E; Flores-Montero J; Rasillo A; Sayagues JM; Sánchez ML; Bárcena P; Hernandez-Rivas JM; Salvador C; Fernandez-Mosteirín N; Giralt M; Perdiguer L; Laranjeira P; Paiva A; Orfao A
    Cytometry B Clin Cytom; 2010 May; 78(3):154-68. PubMed ID: 20198685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral blood MDS score: a new flow cytometric tool for the diagnosis of myelodysplastic syndromes.
    Cherian S; Moore J; Bantly A; Vergilio JA; Klein P; Luger S; Bagg A
    Cytometry B Clin Cytom; 2005 Mar; 64(1):9-17. PubMed ID: 15668954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric analysis of myelomonocytic cells by a pattern recognition approach is sensitive and specific in diagnosing myelodysplastic syndrome and related marrow diseases: emphasis on a global evaluation and recognition of diagnostic pitfalls.
    Stachurski D; Smith BR; Pozdnyakova O; Andersen M; Xiao Z; Raza A; Woda BA; Wang SA
    Leuk Res; 2008 Feb; 32(2):215-24. PubMed ID: 17675229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometry for diagnosis and assessment of prognosis in patients with myelodysplastic syndromes.
    Benesch M; Deeg HJ; Wells D; Loken M
    Hematology; 2004 Jun; 9(3):171-7. PubMed ID: 15204098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New horizons in MDS: flow cytometric diagnosis and a role of immunomodulatory molecules in disease progression].
    Ogata K
    Rinsho Ketsueki; 2011 Mar; 52(3):106-10. PubMed ID: 21471696
    [No Abstract]   [Full Text] [Related]  

  • 10. A single-tube flow cytometric procedure for enhancing the diagnosis and prognostic classification of patients with myelodysplastic syndromes.
    Kárai B; Bedekovics J; Miltényi Z; Gergely L; Szerafin L; Ujfalusi A; Kappelmayer J; Hevessy Z
    Int J Lab Hematol; 2017 Dec; 39(6):577-584. PubMed ID: 28625017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High flow cytometric scores identify adverse prognostic subgroups within the revised international prognostic scoring system for myelodysplastic syndromes.
    Alhan C; Westers TM; Cremers EM; Cali C; Witte BI; Ossenkoppele GJ; van de Loosdrecht AA
    Br J Haematol; 2014 Oct; 167(1):100-9. PubMed ID: 24976502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of flow cytometric immunophenotyping in diagnosis of myelodysplastic syndromes--review].
    Zhang Y; Li X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1477-81. PubMed ID: 19099668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical utility of multiparameter flow cytometry in the diagnosis of 1013 patients with suspected myelodysplastic syndrome: correlation to cytomorphology, cytogenetics, and clinical data.
    Kern W; Haferlach C; Schnittger S; Haferlach T
    Cancer; 2010 Oct; 116(19):4549-63. PubMed ID: 20572043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a Bone Marrow Dysmyelopoiesis Immunophenotypic Index for the Diagnosis and Prognosis of Myelodysplastic Syndromes.
    Verigou E; Lampropoulou P; Smyrni N; Kolliopoulou G; Sakellaropoulos G; Starakis I; Zikos P; Solomou E; Symeonidis A; Karakantza M
    Cardiovasc Hematol Disord Drug Targets; 2015; 15(2):148-61. PubMed ID: 26126819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiparameter flow cytometry provides independent prognostic information in patients with suspected myelodysplastic syndromes: A study on 804 patients.
    Kern W; Bacher U; Haferlach C; Alpermann T; Schnittger S; Haferlach T
    Cytometry B Clin Cytom; 2015; 88(3):154-64. PubMed ID: 25581461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translating the MDS flow cytometric score into clinical practice.
    Heron M; Dovern E; Bakker-Jonges LE; Posthuma EF; Brouwer RE; Smedts F; Batstra MR
    Cytometry B Clin Cytom; 2015; 88(3):207-9. PubMed ID: 25490972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic flow cytometry for low-grade myelodysplastic syndromes.
    Ogata K
    Hematol Oncol; 2008 Dec; 26(4):193-8. PubMed ID: 18412289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of flow cytometry for myelodysplastic syndromes: Pitfalls and technical considerations.
    Alhan C; Westers TM; Cremers EM; Cali C; Ossenkoppele GJ; van de Loosdrecht AA
    Cytometry B Clin Cytom; 2016 Jul; 90(4):358-67. PubMed ID: 26517178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometric detection of dyserythropoiesis: a sensitive and powerful diagnostic tool for myelodysplastic syndromes.
    Mathis S; Chapuis N; Debord C; Rouquette A; Radford-Weiss I; Park S; Dreyfus F; Lacombe C; Béné MC; Kosmider O; Fontenay M; Bardet V
    Leukemia; 2013 Oct; 27(10):1981-7. PubMed ID: 23765225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic relevance of cytometric quantitative assessment in patients with myelodysplastic syndromes.
    Falco P; Levis A; Stacchini A; Ciriello MM; Geuna M; Notari P; Omedè P; Pautasso M; Prato G; Strola G; Gioia D; Bonferroni M; Cametti G; Ferrero D; Freilone R; Gaidano G; Marinone C; Marmont F; Pollio B; Salvi F; Saglio G; Girotto M;
    Eur J Haematol; 2011 Nov; 87(5):409-18. PubMed ID: 21711395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.